Saccharomyces boulardii CNCM I-745
Selected indexed studies
- Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review. (Cureus, 2023) [PMID:37927652]
- Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections. (World J Gastroenterol, 2019) [PMID:31143070]
- Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases. (Curr Microbiol, 2020) [PMID:32472262]
_Worker-drafted node — pending editorial review._
Connections
Saccharomyces boulardii CNCM I-745 helps
Sources
- Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review. (2023) pubmed
- Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study. (2023) pubmed
- Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review. (2018) pubmed
- Saccharomyces boulardii CNCM I-745 in different clinical conditions. (2014) pubmed
- Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections. (2019) pubmed
- Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases. (2020) pubmed
- Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption. (2019) pubmed
- [Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system]. (2017) pubmed
- Saccharomyces boulardii CNCM I-745 mitigates antibiotic-induced gut microbiome functional alterations independently of the host. (2025) pubmed
- Saccharomyces boulardii (CNCM I-745) improves intestinal damage in sepsis by remodeling intestinal flora structure. (2025) pubmed